The WES303 pill is a blue, capsule-shaped medication containing acetaminophen and hydrocodone bitartrate in doses of 325 mg and 10 mg respectively. This prescription medication, manufactured by Eywa Pharma Inc., is primarily used to treat moderate to severe pain.
The WES303 pill presents distinctive physical attributes that make it easily identifiable in the pharmaceutical landscape. Its most notable feature is its striking blue coloration, complemented by a capsule or oblong shape that measures approximately 15mm in length. The pill carries a clear imprint reading “WES 303,” which serves as its unique identifier. In its composition, beyond its active ingredients, the pill contains several inactive components crucial for its formulation, including croscarmellose sodium for improved disintegration, silicon dioxide as an anti-caking agent, magnesium stearate for better flow properties, microcrystalline cellulose as a binding agent, and FD&C Blue No. 1 for its distinctive coloring.
The WES303 pill has distinct identifying features:
The WES303 pill operates through a sophisticated dual-action mechanism that makes it particularly effective for pain management. The hydrocodone component functions as an opioid analgesic, binding to specific receptors in the brain and nervous system to alter pain perception and emotional response to pain. Simultaneously, the acetaminophen component works by inhibiting prostaglandin synthesis in the central nervous system, enhancing the overall pain-relieving effect while also providing antipyretic properties. This synergistic combination makes it particularly effective for managing various types of pain, including severe back pain, post-surgical pain, and chronic pain conditions that haven’t responded adequately to other treatments.
This combination medication works through two primary mechanisms. The hydrocodone component acts as an opioid pain reliever, while acetaminophen enhances the pain-relieving effects. It’s commonly prescribed for:
The safety profile of WES303 requires careful consideration due to its potent ingredients. Patients with certain medical conditions must exercise extreme caution or avoid this medication entirely. Those with severe asthma or other respiratory conditions face increased risks due to the respiratory-depressing effects of hydrocodone. The medication is absolutely contraindicated in patients who have taken MAO inhibitors within the past 14 days due to potentially dangerous drug interactions. Additionally, individuals with gastrointestinal blockages should not take this medication as it can worsen their condition and lead to severe complications.
Do not take this medication if you have:
The side effect profile of WES303 ranges from mild to severe, necessitating careful monitoring during treatment. Common effects such as nausea, vomiting, constipation, lightheadedness, and drowsiness typically manifest early in treatment and may diminish over time as the body adjusts to the medication. However, more serious side effects require immediate medical intervention. These include respiratory depression, characterized by shallow or difficult breathing, severe drowsiness that may indicate overdose, significant mental or mood changes that could signal adverse neurological effects, and urinary retention. These serious effects can indicate potentially life-threatening complications and should never be ignored.
Common side effects include:
Serious side effects requiring immediate medical attention:
Recognizing overdose symptoms is crucial for patient safety when taking WES303. The presentation of blue-tinted lips or fingernails indicates dangerous oxygen deprivation, while cold, clammy skin suggests circulatory problems. Mental confusion, constricted pupils, irregular breathing patterns, and loss of consciousness represent severe overdose symptoms requiring immediate emergency intervention. These signs can progress rapidly and may be life-threatening if not addressed promptly through emergency medical care.
Seek emergency help if you notice:
Proper usage of WES303 requires strict adherence to prescribed guidelines and careful monitoring. The medication should only be taken exactly as prescribed by a healthcare provider, with particular attention to dosing schedules and amounts. Patients must never adjust their dosage independently or share their medication with others, regardless of similar symptoms. Proper storage in a secure location is essential to prevent unauthorized access, particularly by children or individuals with substance use disorders. Regular monitoring for signs of dependency is crucial, as the hydrocodone component carries significant potential for addiction.
This medication requires careful monitoring and proper usage:
Alcohol consumption while taking WES303 poses serious risks that cannot be overstated. The combination of alcohol with this medication can lead to dangerous and potentially fatal respiratory depression. Alcohol enhances the central nervous system depressant effects of hydrocodone, potentially leading to severe drowsiness, impaired cognitive function, and decreased respiratory drive. Additionally, the combination can increase the risk of liver damage due to the acetaminophen component. The interaction between alcohol and WES303 can also result in unpredictable effects on blood pressure and heart rate. For these reasons, complete abstinence from alcohol is necessary throughout the duration of WES303 treatment.
Managing missed doses of WES303 requires careful consideration to maintain therapeutic effectiveness while avoiding potential overdose. When a dose is missed, it should be taken as soon as remembered, unless it’s nearly time for the next scheduled dose. In such cases, the missed dose should be skipped entirely to avoid doubling up, which could lead to dangerous levels of both hydrocodone and acetaminophen in the system. It’s crucial to maintain a consistent dosing schedule while avoiding any attempt to compensate for missed doses by taking extra medication. Keeping a medication diary or setting reminders can help prevent missed doses and maintain proper therapeutic levels.
The onset of action for WES303 involves complex pharmacokinetics that affect its therapeutic timeline. While initial effects typically begin within 30-60 minutes after administration, peak plasma concentrations of both active ingredients occur at different times. The hydrocodone component usually reaches peak effectiveness within 1.3 hours, while acetaminophen peaks slightly earlier. Various factors can influence these timelines, including individual metabolism, food intake, and concurrent medications. The duration of pain relief typically lasts 4-6 hours, though this can vary among individuals. Understanding these timing aspects helps patients maintain optimal pain control while avoiding premature redosing.
The addiction potential of WES303 is significant due to its hydrocodone component, which belongs to the opioid class of medications. Physical dependence can develop even when taking the medication as prescribed, typically manifesting after several weeks of regular use. The risk of psychological dependence, characterized by craving and preoccupation with the medication, varies among individuals but is influenced by factors such as personal or family history of substance use disorders, duration of use, and dosage levels. Signs of developing dependency may include tolerance (needing higher doses for the same effect), withdrawal symptoms between doses, and unsuccessful attempts to stop or reduce use. Regular monitoring by healthcare providers, honest communication about symptoms, and adherence to prescribed dosing schedules are essential in managing these risks.
Remember, this medication is a controlled substance and should only be taken under proper medical supervision. Never adjust your dosage without consulting your healthcare provider, and always store it securely away from others, especially children and pets.
The WES303 pill is a powerful tool for managing pain, but misuse or dependency can lead to serious challenges.
At Asana Recovery, we offer compassionate and evidence-based care for individuals struggling with prescription medication management or dependency. Our personalized programs are designed to help you regain control, address underlying issues, and build a healthier, more balanced life.
If you or a loved one needs support, contact Asana Recovery today. Take the first step toward safe and effective medication use or recovery. We’re here to help.
This book has helped so many men and women; and we want to give it you for FREE. Get signed up today and discover how to unlock the grip of addiction and get back to living your best life.
In this book, you’ll discover…
— The Most Common Misconceptions About Addiction and Rehab
— Why Rock Bottom is a Myth and What You Can Do About It
–The Steps to Healing From Trauma, Both Mentally and Emotionally
–And much more!
Asana Recovery is licensed and certified by the State Department of Health Care Services.
© Copyright 2024 Asana Recovery™ | All Rights Reserved | Privacy Policy
Asana Recovery
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to